Vis enkel innførsel

dc.contributor.authorAmdam, Håkon
dc.contributor.authorNorheim, Ole Frithjof
dc.contributor.authorSolberg, Carl Tollef
dc.contributor.authorLittmann, Jasper
dc.date.accessioned2023-09-29T11:35:34Z
dc.date.available2023-09-29T11:35:34Z
dc.date.created2023-06-19T09:46:29Z
dc.date.issued2023
dc.identifier.issn1754-9973
dc.identifier.urihttps://hdl.handle.net/11250/3093104
dc.description.abstractThis article discusses the fairness of geographically targeted vaccinations (GTVs). During the initial period of local and global vaccine scarcity, health authorities had to enact priority-setting strategies for mass vaccination campaigns against COVID-19. These strategies have in common that priority setting was based on personal characteristics, such as age, health status or profession. However, in 2021, an alternative to this strategy was employed in some countries, particularly Norway. In these countries, vaccine allocation was also based on the epidemiological situations in different regions, and vaccines were assigned based on local incidence rates. The aim of this article is to describe and examine how a geographical allocation mechanism may work by considering Norway as a case study and discuss what ethical issues may arise in this type of priority setting. We explain three core concepts: priority setting, geographical priority setting and GTVs. With a particular focus on Norway, we discuss the potential effects of GTV, the public perception of such a strategy, and if GTV can be considered a fair strategy. We conclude that the most reasonable defence of GTV seems to be through a consequentialist account that values both total health outcomes and more equal outcomes.en_US
dc.language.isoengen_US
dc.publisherOxford University Pressen_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleCan Geographically Targeted Vaccinations Be Ethically Justified? The Case of Norway During the COVID-19 Pandemicen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2023 The Author(s)en_US
cristin.ispublishedfalse
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1093/phe/phad011
dc.identifier.cristin2155649
dc.source.journalPublic Health Ethicsen_US
dc.source.pagenumber139-151en_US
dc.identifier.citationPublic Health Ethics. 2023, 16 (2), 139-151.en_US
dc.source.volume16en_US
dc.source.issue2en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal